| Schedule of Basic and Diluted Net Income (Loss) Per Share |
The
computation of basic and diluted net income (loss) per share for the three months ended June 30, 2026 and 2025 was as follows:
Schedule
of Basic and Diluted Net Income (Loss) Per Share
| | |
2026 | | |
2025 | |
| | |
Three Months Ended June 30, | |
| | |
2026 | | |
2025 | |
| Numerator: | |
| | |
| |
| Net income (loss) | |
$ | 706 | | |
$ | (24,524 | ) |
| Earnings allocated to participating warrants | |
| (160 | ) | |
| - | |
| Deemed dividend relating to inducement of Dragasac warrants | |
| | | |
| | |
| Net income (loss) allocated to common shareholders | |
$ | 546 | | |
$ | (24,524 | ) |
| | |
| | | |
| | |
| Denominator: | |
| | | |
| | |
| Weighted-average shares outstanding - basic | |
| 29,204,376 | | |
| 24,020,193 | |
| Effect of dilutive securities: | |
| | | |
| | |
| Restricted stock units | |
| 140,288 | | |
| - | |
| Weighted-average shares outstanding - diluted | |
| 29,344,664 | | |
| 24,020,193 | |
| | |
| | | |
| | |
| Net income (loss) per share: | |
| | | |
| | |
| Basic | |
$ | 0.02 | | |
$ | (1.02 | ) |
| Diluted | |
$ | 0.02 | | |
$ | (1.02 | ) |
The
computation of basic and diluted net income (loss) per share for the six months ended June 30, 2026 and 2025 was as follows:
| | |
2026 | | |
2025 | |
| | |
Six Months Ended June 30, | |
| | |
2026 | | |
2025 | |
| Numerator: | |
| | |
| |
| Net income (loss) | |
$ | 1,580 | | |
$ | (44,278 | ) |
| Earnings allocated to participating warrants | |
| (359 | ) | |
| - | |
| Deemed dividend relating to inducement of Dragasac warrants | |
| - | | |
| (64 | ) |
| Net income (loss) allocated to common shareholders | |
$ | 1,221 | | |
$ | (44,342 | ) |
| | |
| | | |
| | |
| Denominator: | |
| | | |
| | |
| Weighted-average shares outstanding - basic | |
| 29,136,603 | | |
| 23,775,535 | |
| Effect of dilutive securities: | |
| | | |
| | |
| Restricted stock units | |
| 212,326 | | |
| - | |
| Weighted-average shares outstanding - diluted | |
| 29,348,929 | | |
| 23,775,535 | |
| | |
| | | |
| | |
| Net income (loss) per share: | |
| | | |
| | |
| Basic | |
$ | 0.04 | | |
$ | (1.86 | ) |
| Diluted | |
$ | 0.04 | | |
$ | (1.86 | ) |
|
| Schedule of Potentially Dilutive Securities |
The
following potentially dilutive securities have been excluded from the computation of diluted weighted-average shares of Class A common
stock outstanding as they would be anti-dilutive:
Schedule of Potentially Dilutive Securities
| | |
2026 | | |
2025 | |
| | |
June 30, | |
| | |
2026 | | |
2025 | |
| Stock options | |
| 3,848,739 | | |
| 4,149,592 | |
| Restricted stock units | |
| - | | |
| 558,530 | |
| Market condition stock units | |
| 28,665 | | |
| — | |
| Warrants | |
| 25,774,577 | | |
| 11,633,302 | |
| Convertible debt | |
| 1,885,542 | | |
| 972,094 | |
| Total | |
| 31,537,523 | | |
| 17,313,518 | |
| Anti-dilutive securities | |
| 31,537,523 | | |
| 17,313,518 | |
|